Updated interim Zika clinical guidance for pregnant women and data on contraceptive use to decrease Zika-affected pregnancies
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Updated interim Zika clinical guidance for pregnant women and data on contraceptive use to decrease Zika-affected pregnancies

Filetype[PDF-3.30 MB]


English
Details Supporting Files Related Documents You May Also Like

Details:

  • Personal Author:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Clinician Outreach and Communication Activity (COCA); Clinician Resources; COCA Calls/Webinars Calls/Webinars - 2016Zika Virus: Aug 9, 2016.

    CDC’s top priority for the Zika response is to protect pregnant women and their fetuses from the adverse effects of Zika virus infection in pregnancy. As a result, CDC continues to evaluate all available evidence and update recommendations as new information becomes available. CDC has updated its interim guidance for U.S. healthcare providers caring for pregnant women with possible Zika virus exposure based on emerging evidence about laboratory testing for the diagnosis of Zika. A primary strategy to reduce Zika-related pregnancy complications is to prevent pregnancy among women who want to delay or avoid pregnancy. CDC published contraceptive use data for states where mosquito-borne transmission of Zika is possible. During this COCA Call, clinicians will learn about the updated CDC interim guidance for caring for pregnant women with possible Zika virus exposure, and strategies for increasing access to contraceptive methods and services to minimize the number of pregnancies affected by Zika.

    Objectives:

    • Discuss revised diagnostic testing for Zika virus infection among pregnant women.

    • Discuss clinical management of pregnant women with confirmed or possible Zika virus infection.

    • Review use of a range of contraceptive methods in states, with a focus on highly effective methods.

    • Define strategies for increasing access and availability to highly effective contraception.

    Presentations about: Update: Interim guidance for health care providers caring for pregnant women with possible Zika virus exposure - United States, July 2016. July 29, 2016. MMWR. Morbidity and mortality weekly report ; v. 65, no. 29, p. 739-444. and: Contraceptive use among nonpregnant and postpartum women at risk for unintended pregnancy, and female high school students, in the context of Zika preparedness - United States, 2011-2013 and 2015. August 5, 2016. MMWR. Morbidity and mortality weekly report ; v. 65, no. 30, p. 780-787.

    coca_call_8_9_16.pdf

  • Subjects:
  • Series:
    COCA Conference Call
  • Document Type:
    Presentation
  • Pages in Document:
    70 unnumbered slides
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

More +

Related Documents

You May Also Like

Checkout today's featured content at stacks.cdc.gov